Get the Stockscreener App
1.12
0.90%
0.01
After Hours:
1.12
Autonomix Medical Inc stock is traded at $1.12, with a volume of 91,547.
It is up +0.90% in the last 24 hours and down -0.88% over the past month.
Autonomix Medical Inc is a development-stage medical device development company focused on advancing technologies for sensing and treating disorders relating to the nervous system. Its first-in-class technology platform includes a catheter-based microchip-enabled array that can detect and differentiate neural signals with a high degree of sensitivity as demonstrated in animal studies.
See More
Previous Close:
$1.11
Open:
$1.12
24h Volume:
91,547
Relative Volume:
0.07
Market Cap:
$6.26M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-4.27%
1M Performance:
-0.88%
6M Performance:
-39.46%
1Y Performance:
-93.17%
1-Day Range:
$1.10
$1.16
1-Week Range:
$1.09
$1.2022
52-Week Range:
$0.9612
$21.49
Autonomix Medical Inc Stock (AMIX) Company Profile
Name
Autonomix Medical Inc
Sector
Industry
Phone
832-277-7816
Address
21 WATERWAY AVENUE, SUITE 300, THE WOODLANDS
Compare AMIX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AMIX
Autonomix Medical Inc
|
1.12 | 6.26M | 0 | 0 | 0 | 0.00 |
|
ABT
Abbott Laboratories
|
131.33 | 232.75B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
99.87 | 152.19B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
377.11 | 146.55B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
93.43 | 120.61B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
76.05 | 45.54B | 5.69B | 1.41B | 577.90M | 6.95 |
Autonomix Medical Inc Stock (AMIX) Latest News
Will Autonomix Medical Inc. stock go up soon2025 Market WrapUp & Safe Capital Preservation Plans - newser.com
Shorts Report: Is Autonomix Medical Inc.’s ROE strong enough2025 Year in Review & Real-Time Buy Signal Alerts - خودرو بانک
How to forecast Autonomix Medical Inc. trends using time seriesMarket Volume Summary & Fast Exit and Entry Strategy Plans - newser.com
Day Trade: Will Magna International Inc benefit from green energy policiesBull Run & Weekly Watchlist for Hot Stocks - خودرو بانک
How to escape a deep drawdown in Autonomix Medical Inc.2025 Breakouts & Breakdowns & Daily Profit Maximizing Trade Tips - newser.com
Aug Summary: Is NeuroSense Therapeutics Ltd a momentum stockJuly 2025 Selloffs & Reliable Momentum Entry Alerts - خودرو بانک
Fed Meeting: Does CaliberCos Inc. offer margin of safetyTrade Analysis Report & AI Driven Stock Price Forecasts - خودرو بانک
Real time social sentiment graph for Autonomix Medical Inc.Weekly Profit Recap & Stepwise Trade Signal Guides - newser.com
Building trade automation scripts for Autonomix Medical Inc.2025 Winners & Losers & Detailed Earnings Play Strategies - newser.com
Can Autonomix Medical Inc. recover in the next quarterWall Street Watch & Community Verified Swing Trade Signals - newser.com
Autonomix Medical Inc. stock momentum explainedPortfolio Value Summary & Weekly High Momentum Picks - newser.com
What to expect from Autonomix Medical Inc. in the next 30 daysBull Run & Verified Stock Trade Ideas - newser.com
What data driven models say about Autonomix Medical Inc.’s future2025 Pullback Review & Free Verified High Yield Trade Plans - newser.com
Combining machine learning predictions for Autonomix Medical Inc.July 2025 Sector Moves & Stepwise Entry and Exit Trade Signals - newser.com
How to recover losses in Autonomix Medical Inc. stockQuarterly Earnings Report & Reliable Price Breakout Signals - newser.com
Short Interest in Autonomix Medical, Inc. (NASDAQ:AMIX) Decreases By 22.2% - Defense World
Can Autonomix Medical Inc. outperform under higher oil pricesJuly 2025 Price Swings & Comprehensive Market Scan Reports - Lancaster City Council
Autonomix announces longer-term post hoc data from PoC 1 trial - MSN
What analysts say about Autonomix Medical Inc. stockEarnings Recap Summary & Fast Gain Stock Trading Tips - Lancaster City Council
Autonomix Medical, Inc. Announces Abstract Accepted for Podium Presentation at the 2025 CIRSE Annual Congress - GlobeNewswire
Revolutionary Nerve-Targeted Pain Treatment: Autonomix Medical Presents First Human Trial Results at CIRSE 2025 - Stock Titan
Pattern Scan Adds Autonomix Medical Inc. to WatchlistBear Alert & Daily Risk Controlled Trade Plans - beatles.ru
What recovery options are there for Autonomix Medical Inc.Long Setup & Safe Capital Growth Stock Tips - Newser
Key resistance and support levels for Autonomix Medical Inc.2025 Top Decliners & Community Verified Trade Alerts - Newser
Is Autonomix Medical Inc. in a consolidation phaseWeekly Risk Summary & Verified Momentum Watchlists - خودرو بانک
What’s the beta of Autonomix Medical Inc. stockWeekly Stock Recap & AI Driven Stock Movement Reports - خودرو بانک
Heatmap analysis for Autonomix Medical Inc. and competitorsMarket Trend Report & Capital Protection Trade Alerts - Newser
What’s next for Autonomix Medical Inc. stockJuly 2025 Weekly Recap & Daily Entry Point Alerts - خودرو بانک
Real time scanner hits for Autonomix Medical Inc. explainedJuly 2025 Selloffs & Fast Momentum Stock Entry Tips - Newser
Is Autonomix Medical Inc. a top pick in the sectorTrade Risk Summary & High Return Stock Watch Alerts - خودرو بانک
What’s the analyst consensus on Autonomix Medical Inc.July 2025 Rallies & Low Drawdown Trading Techniques - خودرو بانک
Analyzing Autonomix Medical Inc. with multi timeframe chartsQuarterly Investment Review & Daily Stock Trend Reports - Newser
Autonomix Medical (AMIX) Q1 2026 Earnings Miss Sparks Sharp Sell-Off, Despite Resilient Healthcare Sector - AInvest
Visual trend scoring systems applied to Autonomix Medical Inc.Oil Prices & Daily Momentum Trading Reports - Newser
What’s Autonomix Medical Inc.’s historical returnJuly 2025 Institutional & Technical Buy Zone Confirmations - خودرو بانک
Autonomix Medical, Inc. (NASDAQ: AMIX) Participates in Virtual Investor “What This Means” Segment - GlobeNewswire
Autonomix Medical Announces Positive Results from Proof-of-Concept Human Clinical Trial for Pain Management. - AInvest
100% Zero Opioid Use: Autonomix Medical's Nerve Technology Shows Sustained Pain Reduction in Clinical Trial - Stock Titan
Is Autonomix Medical Inc. a candidate for recovery playMarket Activity Recap & Daily Volume Surge Signals - Newser
Will Autonomix Medical Inc. stock recover after recent dropWeekly Trend Summary & High Accuracy Trade Signal Alerts - Newser
Candlestick signals on Autonomix Medical Inc. stock todayWeekly Investment Report & Weekly Watchlist for Hot Stocks - Newser
Applying chart zones and confluence areas to Autonomix Medical Inc.July 2025 Big Picture & Weekly Market Pulse Updates - Newser
Order flow analysis tools used on Autonomix Medical Inc.Earnings Growth Summary & Long-Term Safe Investment Plans - Newser
Analyzing net buyer seller activity in Autonomix Medical Inc.Gap Down & Entry and Exit Point Strategies - Newser
Measuring Autonomix Medical Inc.’s beta against major indicesJuly 2025 Momentum & Low Risk High Reward Trade Ideas - Newser
Does Autonomix Medical Inc. have consistent dividend growthJuly 2025 Snapshot & AI Powered Market Entry Ideas - خودرو بانک
Smart tools for monitoring Autonomix Medical Inc.’s price actionMarket Growth Report & High Conviction Investment Ideas - Newser
Is Autonomix Medical Inc. currently under institutional pressureLayoff News & Real-Time Stock Entry Alerts - خودرو بانک
Autonomix Medical, Inc. Demonstrates Sustained Pain Reduction, Quality of Life Gains and 100% Zero Opioid Use in Longer-Term Post Hoc Analysis from PoC 1 Study - The Manila Times
Autonomix Medical Demonstrates Long-Term Pain Relief and Opioid-Free Status in Pancreatic Cancer Patients - AInvest
Autonomix Medical, Inc. Demonstrates Sustained Pain - GlobeNewswire
Autonomix Medical Inc Stock (AMIX) Financials Data
There is no financial data for Autonomix Medical Inc (AMIX). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.44%
1.73%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):